Poultry Vaccines Section
The Poultry Vaccines Section focuses on the development, production, and quality assurance of vaccines for the prevention of infectious diseases in poultry. This division supports the poultry industry by providing reliable, effective, and affordable biologicals that help safeguard animal health and productivity.
Overview
The Poultry Vaccines Section is dedicated to the production of vaccines against major poultry diseases. It incorporates modern techniques of virus cultivation, inactivation, blending, and formulation under strict biosafety and GMP conditions.
The section ensures uninterrupted supply of vaccines essential for the prevention of contagious diseases affecting the poultry industry and rural livelihood sectors.
Major Vaccines Produced
- Newcastle Disease Vaccine (F1 Strain) — Live attenuated vaccine for broilers and layers.
- Fowl Pox Vaccine — Lyophilized live vaccine for protection against fowl pox.
- Infectious Bursal Disease Vaccine — Vaccine providing immunity against Gumboro disease.
- Marek’s Disease Vaccine — Cell-associated vaccine ensuring long-term protection in chicks.
Infrastructure and Facilities
The unit houses biosecure laboratories, clean rooms, embryo inoculation facilities, laminar airflow workstations, and controlled lyophilization units. All equipment and production lines are validated for consistent and sterile output.
Research and Development
Continuous R&D efforts focus on strain improvement, vaccine stability enhancement, and development of multivalent formulations. Collaborative studies are conducted with leading poultry research institutes.
Quality Assurance
Every vaccine batch is subjected to safety, potency, and purity evaluations before release. The section adheres to OIE and national veterinary biological standards ensuring reliable immunization outcomes.